Cargando…
Transforming growth factor β1 accelerates and enhances in vitro red blood cell formation from hematopoietic stem cells by stimulating mitophagy
BACKGROUND: Generation of red blood cells (RBCs) from hematopoietic stem cells (HSCs) in vitro takes about 21 days, making it unaffordable for clinical applications. Acceleration of the in vitro erythropoiesis process by using small molecules could eventually make the large-scale production of these...
Autores principales: | Kuhikar, Rutuja, Khan, Nikhat, Philip, Joseph, Melinkeri, Sameer, Kale, Vaijayanti, Limaye, Lalita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029523/ https://www.ncbi.nlm.nih.gov/pubmed/32075694 http://dx.doi.org/10.1186/s13287-020-01603-z |
Ejemplares similares
-
Autologous Hematopoietic Stem Cells Are a Preferred Source to Generate Dendritic Cells for Immunotherapy in Multiple Myeloma Patients
por: Shinde, Prajakta, et al.
Publicado: (2019) -
Compromised functionality of monocyte-derived dendritic cells in multiple myeloma patients may limit their use in cancer immunotherapy
por: Shinde, Prajakta, et al.
Publicado: (2018) -
Nitric oxide has contrasting age-dependent effects on the functionality of murine hematopoietic stem cells
por: Jalnapurkar, Sapana, et al.
Publicado: (2016) -
Umbilical cord blood-derived CD11c(+) dendritic cells could serve as an alternative allogeneic source of dendritic cells for cancer immunotherapy
por: Kumar, Jeetendra, et al.
Publicado: (2015) -
Differential ability of MSCs isolated from placenta and cord as feeders for supporting ex vivo expansion of umbilical cord blood derived CD34(+) cells
por: Kadekar, Darshana, et al.
Publicado: (2015)